Peter L. Hoang

Insider Reports History

Entity
Individual
Location
C/O Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston, TX
Signature
/s/ Michael Loiacono, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter L. Hoang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Marker Therapeutics, Inc. President and CEO, Director Common Stock 483K $234K $0.48 Mar 24, 2022 Direct

Insider Reports Filed by Peter L. Hoang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRKR Marker Therapeutics, Inc. Mar 24, 2022 2 -$23.5K 4 Mar 28, 2022 President and CEO, Director
MRKR Marker Therapeutics, Inc. Feb 17, 2022 1 $0 4 Feb 22, 2022 President and CEO, Director